SAN FRANCISCO (CBS.MW) -- Dade Behring Holdings Inc. said after the bell Thursday that its NT-proBNP test has received clearance for expanded use from the U.S. Food and Drug Administration. The test ...
Hosted on MSN
What Is Congestive Heart Failure?
Congestive heart failure (CHF) is the term used to describe what happens when the heart is unable to pump enough blood to meet the body’s needs. (It should not be confused with cardiac arrest in which ...
(WISH) — The use of smartwatches in detecting congestive heart failure could revolutionize early diagnosis and treatment, offering a promising tool for patients and health care providers alike.
Managing heart failure can be challenging as patients typically need to wait for blood tests to be performed and processed by a skilled technician. This creates a noticeable lag between the ...
Diastolic heart failure means there’s a problem with your heart’s ability to fill with blood. It’s a type of congestive heart failure where your heart cannot work efficiently, leading to fluid ...
Hosted on MSN
What To Know About Systolic Congestive Heart Failure
Systolic congestive heart failure involves the left side of your heart losing its ability to pump effectively. Common symptoms include shortness of breath, weight gain, and swelling in your legs or ...
You can follow a treatment plan and take medications as a doctor prescribes to manage congestive heart failure. Eat a heart-healthy diet and stay physically active to slow heart failure progression.
A recent study has found that people with congestive heart failure have different microbes on their tongues than people without the condition. This could lead to new ways of testing for heart ...
From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart ...
TULSA, Okla. — Some people with congestive heart failure are getting the chance to try a new treatment. Saint Francis is in the middle of a two-year double-blind clinical trial for a device that could ...
Using patient-derived cardiac tissue and stem cell-based models, the team of translational researchers demonstrated that targeting the genetic cause of disease improved cellular abnormalities and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results